Related Experiment Videos
Novel, highly potent, selective 5-HT2A/D2 receptor antagonists as potential atypical antipsychotics
Taekyu Lee1, Albert J Robichaud, Kristopher E Boyle
1Discovery Chemistry, Bristol-Myers Squibb Company, Wilmington, DE 19880, USA. taekyu.lee@bms.com
Bioorganic & Medicinal Chemistry Letters
|March 18, 2003
Abstract:
The discovery of N-substituted-pyridoindolines and their binding affinities at the 5-HT(2A), 5-HT(2C) and D(2) receptors, and in vivo efficacy as 5-HT(2A) antagonists is described. The structure-activity relationship of a series of core tetracyclic derivatives with varying butyrophenone sidechains is also discussed. This study has led to the identification of potent, orally bioavailable 5-HT(2A)/D(2) receptor dual antagonists as potential atypical antipsychotics.